Oncopeptides AB (publ) announced that Sofia Heigis who will move from the CCO role to take on the CEO role.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.288 SEK | -1.56% | +22.14% | -56.79% |
05-30 | Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank | MT |
05-30 | Transcript : Oncopeptides AB, Q1 2024 Earnings Call, May 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.79% | 68.78M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+3.09% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Announces Sofia Heigis to Move from the CCO Role to CEO Role